Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.

Article  PubMed  Google Scholar 

Satija A, Spiegelman D, Giovannucci E, Hu FB. Type 2 diabetes and risk of cancer. BMJ. 2015;350:g7707.

Article  PubMed  Google Scholar 

Grote VA, Becker S, Kaaks R. Diabetes mellitus type 2 - an independent risk factor for cancer? Exp Clin Endocrinol Diabetes. 2010;118(1):4–8.

Article  CAS  PubMed  Google Scholar 

Sciacca L, Vigneri R, Tumminia A, Frasca F, Squatrito S, Frittitta L, et al. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients. Nutr Metab Cardiovasc Dis. 2013;23(9):808–15.

Article  CAS  PubMed  Google Scholar 

Perry RJ, Shulman GI. Mechanistic Links between Obesity, Insulin, and Cancer. Trends Cancer. 2020;6(2):75–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Larsson SC, Spyrou N, Mantzoros CS. Body fatness associations with cancer: evidence from recent epidemiological studies and future directions. Metabolism. 2022;137:155326.

Article  CAS  PubMed  Google Scholar 

Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nicolaisen SK, Thomsen RW, Lau CJ, Sorensen HT, Pedersen L. Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark. BMJ Open Diabetes Res Care. 2022;10(5).

Gribsholt SB, Cronin-Fenton D, Veres K, Thomsen RW, Ording AG, Richelsen B, et al. Hospital-diagnosed overweight and obesity related to cancer risk: a 40-year Danish cohort study. J Intern Med. 2020;287(4):435–47.

Article  CAS  PubMed  Google Scholar 

Kim DS, Scherer PE. Obesity, Diabetes, and Increased Cancer Progression. Diabetes Metab J. 2021;45(6):799–812.

Article  PubMed  PubMed Central  Google Scholar 

Ling S, Brown K, Miksza JK, Howells L, Morrison A, Issa E, et al. Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People. Diabetes Care. 2020;43(9):2313–22.

Article  PubMed  Google Scholar 

Gurney J, Stanley J, Teng A, Krebs J, Koea J, Lao C, et al. Cancer and diabetes co-occurrence: A national study with 44 million person-years of follow-up. PLoS One. 2022;17(11):e0276913.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ling S, Brown K, Miksza JK, Howells LM, Morrison A, Issa E, et al. Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts. Nutr Metab Cardiovasc Dis. 2021;31(1):14–22.

Article  PubMed  Google Scholar 

Magruder JT, Elahi D, Andersen DK. Diabetes and pancreatic cancer: chicken or egg? Pancreas. 2011;40(3):339–51.

Article  PubMed  Google Scholar 

Collins KK. The diabetes-cancer link. Diabetes Spectr. 2014;27(4):276–80.

Article  PubMed  PubMed Central  Google Scholar 

Hope C, Robertshaw A, Cheung KL, Idris I, English E. Relationship between HbA1c and cancer in people with or without diabetes: a systematic review. Diabet Med. 2016;33(8):1013–25.

Article  CAS  PubMed  Google Scholar 

Miao Jonasson J, Cederholm J, Eliasson B, Zethelius B, Eeg-Olofsson K, Gudbjornsdottir S. HbA1C and cancer risk in patients with type 2 diabetes--a nationwide population-based prospective cohort study in Sweden. PLoS One. 2012;7(6):e38784.

Article  PubMed  PubMed Central  Google Scholar 

Iacobini C, Vitale M, Pugliese G, Menini S. The “sweet” path to cancer: focus on cellular glucose metabolism. Front Oncol. 2023;13:1202093.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menendez JA, Joven J, Cufi S, Corominas-Faja B, Oliveras-Ferraros C, Cuyas E, et al. The warburg effect version 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle. 2013;12(8):1166–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kozal K, Krzeslak A. The role of hypoxia-inducible factor isoforms in breast cancer and perspectives on their inhibition in therapy. Cancers (Basel). 2022;14(18):4518.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahmoon MA, Elghaish RA, Ibrahim AA, Alaswad Z, Gad MZ, El-Khamisy SF, et al. High glucose increases DNA damage and elevates the expression of multiple DDR genes. Genes. 2023. https://doi.org/10.3390/genes14010144.

Article  PubMed  PubMed Central  Google Scholar 

Lim JS, Kim S, Cho IY, Shin DW. Obesity and cancer: mechanisms, epidemiological evidence, and potential risk reduction. J Obes Metab Syndr. 2026;35(1):14–37.

Article  PubMed  PubMed Central  Google Scholar 

Natalicchio A, Montagnani M, Gallo M, Marrano N, Faggiano A, Zatelli MC, et al. MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view. ESMO Open. 2023;8(3):101573.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi MM, Mantovani A. Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb). 2011;21(3):264–75.

Article  CAS  PubMed  Google Scholar 

Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, Zuppi C, et al. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud. 2010;7(1):15–25.

Article  PubMed  PubMed Central  Google Scholar 

Dariya B, Nagaraju GP. Advanced glycation end products in diabetes, cancer and phytochemical therapy. Drug Discov Today. 2020;25(9):1614–23.

Article  CAS  PubMed  Google Scholar 

Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, et al. Gut microbiota influence tumor development and alter interactions with the human immune system. J Exp Clin Cancer Res. 2021;40(1):42.

Article  PubMed  PubMed Central  Google Scholar 

Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330–9.

Article  PubMed  Google Scholar 

Park CH, Eun CS, Han DS. Intestinal microbiota, chronic inflammation, and colorectal cancer. Intest Res. 2018;16(3):338–45.

Article  PubMed  PubMed Central  Google Scholar 

Peng H, Pan Y, Sun Y, Wang X, Fan X, Wang Y, et al. Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis. J Immunother Cancer. 2025;13(6):e011310.

Article  PubMed  PubMed Central  Google Scholar 

Rodrigues Mantuano N, Stanczak MA, Oliveira IA, Kirchhammer N, Filardy AA, Monaco G, et al. Hyperglycemia enhances cancer immune evasion by inducing alternative macrophage polarization through increased O-GlcNAcylation. Cancer Immunol Res. 2020;8(10):1262–72.

Article  PubMed  Google Scholar 

Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha. Cell Metab. 2022;34(9):1312-24 e6.